Abnormal lipid concentrations in cystic fibrosis

American Journal of Clinical Nutrition

Volumn 75, Issue 6, 2002, Pages 1005-1011

  Figueroa, Veronica ^a   Milla, Carlos ^a   Parks, Elizabeth J ^a   Schwarzenberg, Sarah Jane ^a   Moran, Antoinette ^a,b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Cholesterol; Cystic fibrosis; Cystic fibrosis related diabetes; Glucose tolerance; Hypertriglyceridemia; Triacylglycerol

Indexed keywords

C REACTIVE PROTEIN; CARBOHYDRATE; CHOLESTEROL; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; INSULIN; LIPID; LIVER ENZYME; TRIACYLGLYCEROL;

ADULT; AREA UNDER THE CURVE; ARTICLE; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORRELATION ANALYSIS; CYSTIC FIBROSIS; FEMALE; GENOTYPE; HUMAN; HYPERTRIGLYCERIDEMIA; INFLAMMATION; LUNG FUNCTION; MACRONUTRIENT; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; NUTRITIONAL STATUS; ORAL GLUCOSE TOLERANCE TEST; WEIGHT;

EID: 0036106187     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/75.6.1005     Document Type: Article

References (38)

1. Role of insulin resistance in human disease
2. Management of dyslipidemia in IDDM patients
3. Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose: The Funagata Diabetes Study
4. Abnormal glucose metabolism in cystic fibrosis
5. Report of the Expert Panel on Blood Cholesterol Levels in Children and Adolescents
6. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge
7. Plasma cholesterol and triglyceride distributions in 13,665 children and adolescents: The prevalence study of the Lipid Research Clinics Program
8. Lipoprotein lipase
9. Insulin resistance in the pathogenesis of dyslipidemia
10. Ursodeoxycholic acid improves the hepatic metabolism of essential fatty acids and retinol in children with CF
11. Hyperlipidemic response to endotoxin-a part of the host-defence mechanism
12. The metabolic effects of tumor necrosis factor and other cytokines
13. Tumor necrosis factor-alpha stimulates hepatic lipogenesis in the rat in vivo
14. Mechanisms by which tumor necrosis factor stimulates hepatic fatty acid synthesis
15. Circulating tumor necrosis factor alpha levels and lipid abnormalities in patients with CF
16. Carbohydrate-induced hypertriacylglycerolemia: Historical perspective and review of biological mechanisms
17. Nutritional assessment and management in cystic fibrosis: A consensus report
18. Protein metabolism in clinically stable adult CF patients with abnormal glucose tolerance
19. Fatty acid pool size in plasma lipoprotein fractions of cystic fibrosis patients
20. Comparison of the macronutrient intake of healthy controls and children with cystic fibrosis on low fat or nonrestricted fat diets
21. Fat intake is low in cystic fibrosis despite unrestricted dietary practices
22. Fat malabsorption in CF patients receiving enzyme replacement therapy is due to impaired intestinal uptake of long-chain fatty acids
23. Enhanced glucose absorption in the jejunum of patients with cystic fibrosis
24. Intestinal permeability in cystic fibrosis in relation to genotype
25. Endogenous and exogenous insulin responses in patients with cystic fibrosis
26. Plasma lipid concentrations in children with cystic fibrosis: The value of a high-fat diet and pancreatic supplementation
27. Lipid malabsorption in CF
28. An abnormality in AA/DHA metabolism is present in CFTR-regulated tissues from CF patients
29. Essential fatty acid deficiency in well nourished young cystic fibrosis patients
30. Long chain non-esterified fatty acid pattern in plasma of CF patients and their parents
31. Serum fatty acid profiles in CF patients and their parents
32. Triglyceride as a risk factor for coronary artery disease
33. Is hypertriglyceridaemia an independent risk factor for coronary heart disease?
34. Triglyceride as a risk factor for coronary artery disease
35. Lipid metabolism in adults with CF